These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9890944)

  • 21. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.
    Choe H; Li W; Wright PL; Vasilieva N; Venturi M; Huang CC; Grundner C; Dorfman T; Zwick MB; Wang L; Rosenberg ES; Kwong PD; Burton DR; Robinson JE; Sodroski JG; Farzan M
    Cell; 2003 Jul; 114(2):161-70. PubMed ID: 12887918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 structural plasticity shapes HIV-1 phenotypic properties.
    Colin P; Zhou Z; Staropoli I; Garcia-Perez J; Gasser R; Armani-Tourret M; Benureau Y; Gonzalez N; Jin J; Connell BJ; Raymond S; Delobel P; Izopet J; Lortat-Jacob H; Alcami J; Arenzana-Seisdedos F; Brelot A; Lagane B
    PLoS Pathog; 2018 Dec; 14(12):e1007432. PubMed ID: 30521629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5.
    Monde K; Maeda Y; Tanaka Y; Harada S; Yusa K
    J Biol Chem; 2007 Dec; 282(51):36923-32. PubMed ID: 17971448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7.
    Aarons EJ; Beddows S; Willingham T; Wu L; Koup RA
    Virology; 2001 Sep; 287(2):382-90. PubMed ID: 11531415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.
    Maeda K; Das D; Yin PD; Tsuchiya K; Ogata-Aoki H; Nakata H; Norman RB; Hackney LA; Takaoka Y; Mitsuya H
    J Mol Biol; 2008 Sep; 381(4):956-74. PubMed ID: 18590744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.
    Lin G; Lee B; Haggarty BS; Doms RW; Hoxie JA
    J Virol; 2001 Nov; 75(22):10766-78. PubMed ID: 11602718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptor.
    Fromme BJ; Coetsee M; Van Der Watt P; Chan MC; Sperling KM; Katz AA; Flanagan CA
    AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1527-36. PubMed ID: 19018669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5.
    Tam K; Schultz M; Reyes-Robles T; Vanwalscappel B; Horton J; Alonzo F; Wu B; Landau NR; Torres VJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.
    Hung CS; Vander Heyden N; Ratner L
    J Virol; 1999 Oct; 73(10):8216-26. PubMed ID: 10482572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
    Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
    Miyakawa T; Obaru K; Maeda K; Harada S; Mitsuya H
    J Biol Chem; 2002 Feb; 277(7):4649-55. PubMed ID: 11734558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.
    Platt EJ; Durnin JP; Shinde U; Kabat D
    J Mol Biol; 2007 Nov; 374(1):64-79. PubMed ID: 17920626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
    Agrawal L; Vanhorn-Ali Z; Alkhatib G
    J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.